Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
China
· Delayed Price · Currency is CNY 18.29
-0.50 (-2.66%)
Apr 29, 2026, 3:12 PM CST
Beijing Scitop Bio-tech Revenue
Beijing Scitop Bio-tech had revenue of 85.00M CNY in the quarter ending March 31, 2026, with 9.51% growth. This brings the company's revenue in the last twelve months to 373.31M, up 16.16% year-over-year. In the year 2025, Beijing Scitop Bio-tech had annual revenue of 365.92M with 20.85% growth.
Revenue (ttm)
373.31M
Revenue Growth
+16.16%
P/S Ratio
12.91
Revenue / Employee
1.27M
Employees
295
Market Cap
4.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 365.92M | 63.13M | 20.85% |
| Dec 31, 2024 | 302.79M | 3.55M | 1.19% |
| Dec 31, 2023 | 299.24M | -69.92M | -18.94% |
| Jan 1, 2023 | 369.17M | 4.55M | 1.25% |
| Dec 31, 2021 | 364.62M | 25.46M | 7.51% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Assure Tech (Hangzhou) | 453.58M |
| ChemPartner PharmaTech | 1.13B |
| Hangzhou Biotest Biotech | 449.50M |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Jiangsu Bioperfectus Technologies | 339.05M |
| Wuhan Hvsen Biotechnology | 1.74B |
| Shanghai Obio Technology (Group) Corp. | 265.39M |
| Hefei Lifeon Pharmaceutical | 1.55B |